Pfizer Buys Ergonex Pharma Drug
Ergonex Pharma GmbH, a German drug developer backed by VC firm High Tech Beteiligungen, has agreed to sell Terguride, a potential treatment for pulmonary arterial hypertension, to Pfizer Inc. (NYSE: PFE). The deal is structured with milestone payments, although financial terms were not disclosed.
12 May 2010•3 mins read
